Patients with GATA2 deficiency are at high risk for hematologic malignancies and IEI, and patients with MDS exhibit severe peripheral blood monocytopenia and B cell and NK cell lymphopenia. The gene discussed is GATA2; the disease is myelodysplastic syndrome.